Drug profile · INN
eribulin mesylate
ERIBULIN MESYLATE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
eribulin mesylate (ERIBULIN MESYLATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN eribulin mesylate
Brand ERIBULIN MESYLATE
Route INTRAVENOUS
Formulation SOLUTION
Frequently asked questions
What is eribulin mesylate?
eribulin mesylate (ERIBULIN MESYLATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for eribulin mesylate?
ERIBULIN MESYLATE is a marketed brand name for eribulin mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of eribulin mesylate?
eribulin mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.